Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma
2020 ◽
Vol Publish Ahead of Print
◽
2018 ◽
Vol 48
(6)
◽
pp. 689-690
◽